Nova price target lowered to $300 at Cantor Fitzgerald, says buy weakness
Cantor Fitzgerald lowered the firm’s price target on Nova (NVMI) to $300 from $315 and keeps an Overweight rating on the shares. Nova offered ...
Fintel on MSN19h
Cantor Fitzgerald Initiates Coverage of Protara Therapeutics (TARA) with Overweight Recommendation
Fintel reports that on March 14, 2025, Cantor Fitzgerald initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a Overweight recommendation. Analyst Price Forecast Suggests 559.70% Upside As ...
Analysts Are Bullish on Top Healthcare Stocks: Nyxoah (NYXH), Sandoz Group Ltd (SDZXF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nyxoah (NYXH – Research Report), Sandoz Group ...
David Sacks sold $200M in crypto-related holdings before taking White House job, ethics memo says
Of the the assets sold, the documents said that at least $85 million “is directly attributable to Sacks.” The memo, from ...